Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/143886
Title: | Ligase-controlled cyclo-oligomerization of peptides | Authors: | Hemu, Xinya Zhang, Xiaohong Tam, James P. |
Keywords: | Science::Biological sciences | Issue Date: | 2019 | Source: | Hemu, X., Zhang, X., & Tam, J. P. (2019). Ligase-Controlled Cyclo-oligomerization of Peptides. Organic Letters, 21(7), 2029–2032. doi:10.1021/acs.orglett.9b00151 | Journal: | Organic letters | Abstract: | A biomimetic one-step ligase-catalyzed cyclo-oligomerization mediated by butelase 1, an Asn/Asp-specific ligase, is introduced that is time-, concentration-, length-, and sequence-dependent. This reaction yields cyclic mono-, di-, tri-, and tetramers from peptide precursors containing 3-15 amino acids ended with Asn and a His-Val tail. The cyclomonomers were favored when the peptide lengths were >9 amino acids. A turn-forming Pro residue at the P2 position favored the formation of higher-order cyclo-oligomers. | URI: | https://hdl.handle.net/10356/143886 | ISSN: | 1523-7060 | DOI: | 10.1021/acs.orglett.9b00151 | Schools: | School of Biological Sciences | Rights: | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Organic letters, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.orglett.9b00151 | Fulltext Permission: | open | Fulltext Availability: | With Fulltext |
Appears in Collections: | SBS Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ligase Controlled Cyclo-oligomerization of Peptides.pdf | 585.98 kB | Adobe PDF | ![]() View/Open |
SCOPUSTM
Citations
20
13
Updated on Mar 19, 2025
Web of ScienceTM
Citations
20
11
Updated on Oct 31, 2023
Page view(s)
283
Updated on Mar 21, 2025
Download(s) 20
257
Updated on Mar 21, 2025
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.